CervoMed Inc.
Pharmaceutical company · Boston, Massachusetts, United States · Nasdaq: CRVO
CervoMed Inc. is a pharmaceutical company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2015. Its shares trade on Nasdaq under the ticker CRVO. It has reported private securities offerings to the US SEC, most recently $750,001 sold in a notice filed in 2020.
CervoMed at a glance
What does CervoMed do?
Private fundraising reported to the SEC
14 Form D notices; the most recent reported $750,001 sold (2020).
Frequently asked questions about CervoMed
Where is CervoMed headquartered?
CervoMed Inc. is headquartered in Boston, Massachusetts, United States.
What does CervoMed do?
CervoMed Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is CervoMed a public company?
Yes. CervoMed Inc. trades on Nasdaq under the ticker CRVO.
When was CervoMed founded?
The earliest incorporation on record for CervoMed Inc. is in 2015, according to public company registers.
Similar companies
- Transcode Therapeutics, Inc.Boston, Massachusetts, United States
- Akouos, Inc.Boston, Massachusetts, United States
- Astria Therapeutics, Inc.Boston, Massachusetts, United States
- Albireo Pharma, Inc.Boston, Massachusetts, United States
- Atea Pharmaceuticals, Inc.Boston, Massachusetts, United States
- Rhythm Pharmaceuticals, Inc.Boston, Massachusetts, United States
- Tango Therapeutics, Inc.Boston, Massachusetts, United States
- Paratek Pharmaceuticals, Inc.Boston, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences